RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 69.65
-0.40 (-0.57%)
Jun 26, 2026, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 60.56 billion as of June 26, 2026. Its market cap has increased by 74.73% in one year.
Market Cap
60.56B
Enterprise Value
59.82B
Revenue
3.84B
Ranking
n/a
PE Ratio
26.25
Stock Price
69.65
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 60.56B, an increase of 81.37%. That is a compound annual growth rate of 11.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 60.56B | 33.98% |
| Dec 31, 2025 | 45.20B | 222.75% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 136.10B |
| Innovent Biologics | 132.28B |
| Sichuan Kelun-Biotech Biopharmaceutical | 96.21B |
| Akeso | 78.71B |
| Sino Biopharmaceutical | 75.95B |
| Biocytogen Pharmaceuticals (Beijing) | 41.43B |
| 3SBio | 40.16B |
| Shanghai Henlius Biotech | 32.26B |